Faeth Therapeutics (FTH) Prepaid Assets (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Prepaid Assets came in at $465000.0 in Q1 2026, up 5.68% YoY from $440000.0 in Q1 2025, and up 405.43% on a QoQ basis from $92000.0 in Q4 2025.
Faeth Therapeutics (FTH) Prepaid Assets (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Prepaid Assets data on file, last reported at $465000.0 in Q1 2026.
- Quarterly Prepaid Assets rose 5.68% year-over-year to $465000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $465000.0 (up 5.68% YoY) and the FY2025 annual result came in at $92000.0, down 23.33% from the prior year.
- Prepaid Assets advanced to $465000.0 in Q1 2026, from $92000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q1 2022 to a low of $92000.0 in Q4 2025.
- A 5-year average of $833058.8 and a median of $454000.0 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 574.74% — and 2025, when it tumbled 92.33%.
- Tracing FTH's Prepaid Assets over 5 years: stood at $344000.0 in 2022, then soared by 239.53% to $1.2 million in 2023, then sank by 89.73% to $120000.0 in 2024, then fell by 23.33% to $92000.0 in 2025, then surged by 405.43% to $465000.0 in 2026.
- The last three Prepaid Assets figures came in at $465000.0 (Q1 2026), $92000.0 (Q4 2025), and $248000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Faeth Therapeutics | 181.71 Mn | 181.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 465,000.00 |
| Dec 31, 2025 | 92,000.00 |
| Sep 30, 2025 | 248,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 440,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 269,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 454,000.00 |
| Dec 31, 2022 | 344,000.00 |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 293,000.00 |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 547,000.00 |
| Sep 30, 2021 | 1.20 Mn |